DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea · Delayed Price · Currency is KRW

10,960

+360 (3.40%)

At close: Sep 4, 2026

Market Cap	201.91B -17.3%
Revenue (ttm)	148.75B +0.1%
Net Income	4.43B +579.8%
EPS	247.96 +563.8%
Shares Out	18.42M
PE Ratio	44.20
Forward PE	n/a
Dividend	150.00 (1.38%)
Ex-Dividend Date	Jun 29, 2026

Volume	151,157
Open	10,580
Previous Close	10,600
Day's Range	10,500 - 11,460
52-Week Range	7,460 - 24,900
Beta	-0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations

Founded 1984

Employees 308

Stock Exchange KOSDAQ

Ticker Symbol 067080

Full Company Profile

Financial Performance

In 2025, DAE HWA Pharmaceutical's revenue was 143.06 billion, a decrease of -4.25% compared to the previous year's 149.41 billion. Earnings were 1.65 billion, an increase of 211.15%.

Financial Statements